According to RNC Pharma’s Audit of Medical Equipment Retail Sales in Russia database, around 1.9 million of blood pressure monitors worth 3.8 billion rubles (retail prices, VAT included) were sold on the Russian offline and online retail markets in January–March 2025. The sales went up 6.2% in physical and up 8.3% in monetary terms.

The online sales accounted for almost as much as the offline sales. The share of the offline sales, however, has been declining for the past several years—it dropped from 74.4% in 2022 to 47.5% in Q1 2025. 2023 saw a significant decrease in the share of retail pharmacies in physical terms, when it fell by nearly 8 percentage points from 2022. In monetary terms, the share fell from 77.3% in 2022 to 69.6% in 2023, slowing down a little in 2024 to finally drop to 61.5% in January–March 2025.

The rapid decline in the offline sales is due to the fact that more and more customers are starting to shop online. In particular, the online sales in Q1 2025 increased 5.3 times against Q1 2022 in physical and 3.5 times in monetary terms. They also went up 24.2% from Q1 2024 in rubles and 16.9% in units. However, the offline sales grew by only 1.7% in rubles and fell 2.4% in units.

Interestingly, unbranded blood pressure monitors continued to contribute to the growth rates of the online channel, with a share of over 59.7% in January–March 2025. The sales of unbranded devices surged in 2023, increasing by a factor of 6.2 in physical and 4.6 in monetary terms. Unbranded blood pressure monitors, while reproducing the external characteristics of branded devices, are sold at prices several times lower, which stimulates demand.

Japanese blood pressure monitors, A&D and Omron, remain the most popular devices in Russian pharmacies, accounting for 36.7% and 29.2% the sales in monetary terms, respectively. The Swiss company B.Well rounds out the top three—its sales went up 17.4% in rubles. The sales of the top three companies’ devices accounted for nearly 78% of the sales in physical terms.